Jounce Therapeutics To Present At The Jefferies 2015 Immuno-Oncology Summit

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient selection strategies, today announced that Richard Murray, Ph.D., chief executive officer, will present a company overview at the Jefferies 2015 Immuno-Oncology Summit today at 12 p.m. ET in Boston.

Help employers find you! Check out all the jobs and post your resume.